Comprehensive medication guide to Phenylephrine including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0 with Medicare Advantage OTC benefit; some Medicaid plans cover prescribed OTC phenylephrine. Standard commercial insurance typically does not cover OTC medications. FSA/HSA eligible without a prescription.
Estimated Cash Pricing
$6–$9 for Sudafed PE 24-count; as low as $4–$6 for store-brand generic phenylephrine HCl 10 mg tablets; $5–$6 with GoodRx coupon if prescribed.
Medfinder Findability Score
55/100
Summarize with AI
On this page
Phenylephrine is an over-the-counter sympathomimetic drug best known as the active ingredient in Sudafed PE. It belongs to the class of alpha-1 adrenergic agonists — drugs that mimic the effects of adrenaline on blood vessels, causing them to constrict (narrow). In the context of nasal congestion, this vasoconstriction is intended to reduce swelling in the nasal passages and improve airflow.
Phenylephrine is found in dozens of OTC cold, cough, and allergy products, including Sudafed PE, NyQuil, DayQuil, Mucinex Fast-Max, and Benadryl Allergy Plus Sinus. It is also available as a nasal spray (Neo-Synephrine) and as an injectable vasopressor (Vazculep, Biorphen) for hospital use.
In 2026, phenylephrine's oral form is at the center of a major regulatory review. The FDA proposed removing oral phenylephrine from the OTC decongestant monograph in November 2024 based on evidence that it is not effective as a nasal decongestant when swallowed. Phenylephrine nasal spray and injectable forms are not affected by this ruling.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Phenylephrine is a selective alpha-1 adrenergic receptor agonist. When it binds to alpha-1 receptors on the smooth muscle cells of blood vessel walls, it triggers calcium channels to open, causing smooth muscle contraction and vasoconstriction — the narrowing of blood vessels.
In the context of nasal congestion, this mechanism reduces the engorged blood vessels in the nasal mucosa, decreasing swelling and opening the nasal passages. When phenylephrine nasal spray is applied directly to the nose, this mechanism works effectively and quickly. When phenylephrine is swallowed as a tablet, however, it undergoes extensive first-pass metabolism in the intestinal wall (primarily via monoamine oxidase enzymes) before reaching the bloodstream — leaving only about 40% of the dose in circulation and only about 3% available to reach nasal tissue. This is why clinical trials showed no significant difference between oral phenylephrine and placebo for decongestant effect.
For IV phenylephrine (hospital use), the drug is delivered directly into the bloodstream, bypassing all absorption barriers. This makes it highly effective as a vasopressor for raising blood pressure in settings of anesthesia-induced hypotension or septic shock.
10 mg — tablet
Standard OTC oral tablet for adults and children 12+; take every 4 hours as needed; max 6 doses/day
0.25% — nasal spray
Mild-strength nasal spray (Neo-Synephrine); 2-3 sprays per nostril every 4 hours; max 3 consecutive days
0.5% — nasal spray
Regular-strength nasal spray; 2-3 sprays per nostril every 4 hours; max 3 consecutive days
1% — nasal spray
Extra-strength nasal spray; adults and children 12+ only; max 3 consecutive days
10 mg/mL — injection
IV formulation (Vazculep); hospital use only for vasopressor support during anesthesia or septic shock
100 mcg/mL — injection
Dilute IV formulation (Immphentiv); premixed for continuous infusion during anesthesia
Phenylephrine availability in 2026 is uniquely complicated. This is not a traditional supply shortage — manufacturers have not reported production problems, and the medication itself is not on the FDA Drug Shortages database. Instead, availability is being affected by a regulatory-driven voluntary removal from store shelves.
Following the FDA's proposed administrative order to remove oral phenylephrine from the OTC nasal decongestant monograph (November 2024), major pharmacy chains like CVS voluntarily removed single-ingredient oral PE products from their shelves. Availability now varies significantly by store and chain. Phenylephrine nasal spray (Neo-Synephrine) remains widely available and is not affected by the FDA ruling. Combination products containing phenylephrine (such as NyQuil) may still be found in stores, though reformulations are ongoing.
If you're having trouble finding phenylephrine at your usual pharmacy, medfinder can call pharmacies near you to check which ones have it in stock, then text you the results — saving you the frustration of driving to multiple empty shelves.
Phenylephrine is not a controlled substance and does not require a DEA license to prescribe. No special regulatory requirements apply. Any licensed prescriber can recommend or write an order for phenylephrine. For most patients, it is purchased over the counter without any prescription.
Providers who commonly see patients asking about phenylephrine include:
Telehealth providers on platforms such as Teladoc, MDLive, Amazon Clinic, and Hims/Hers can also evaluate cold and allergy symptoms and write prescriptions for phenylephrine or appropriate alternatives — often within the same day, without requiring an in-person visit.
No. Phenylephrine is not a DEA-scheduled controlled substance. It is available over the counter with no purchase restrictions, no ID requirement, and no limits on how much you can buy. This was one of the main reasons it became the dominant OTC decongestant after pseudoephedrine was moved behind the pharmacy counter in 2005-2006 due to its use in methamphetamine production.
Unlike pseudoephedrine (which requires an ID and is logged by pharmacies), any person can walk into any store and purchase phenylephrine products without any restrictions. No prescription or prior authorization is required for any standard OTC formulation of phenylephrine.
Oral phenylephrine is generally well tolerated. The most common side effects include:
Seek emergency care if you experience any of the following:
Know what you need? Skip the search.
Pseudoephedrine (Sudafed)
Most effective oral decongestant; behind-the-counter; requires ID. Strong clinical evidence of efficacy. Can raise blood pressure.
Oxymetazoline (Afrin)
Fast-acting nasal spray; effective for up to 3 days. Risk of rebound congestion with prolonged use.
Fluticasone (Flonase)
Corticosteroid nasal spray; first-line for allergic rhinitis. Takes days to reach full effect but safe for long-term daily use.
Loratadine (Claritin)
Second-generation antihistamine; effective for allergy-driven congestion with minimal sedation. Safe for most adults.
Saline nasal rinse
Drug-free; no side effects; flushes allergens and mucus from nasal passages. Effective for mild congestion.
Prefer Phenylephrine? We can find it.
MAO Inhibitors (MAOIs)
majorContraindicated — risk of life-threatening hypertensive crisis. Do not use within 14 days of MAOI use. Includes isocarboxazid, phenelzine, selegiline, tranylcypromine, linezolid.
Tricyclic antidepressants (TCAs)
moderateCan potentiate pressor effects of phenylephrine, increasing blood pressure risk. Includes amitriptyline, nortriptyline, imipramine, desipramine.
Ergot alkaloids
majorAdditive vasospasm and risk of hypertension. Includes dihydroergotamine (Migranal) and ergotamine (Ergomar). Used for migraine treatment.
Antihypertensive medications
moderatePhenylephrine can counteract the blood pressure-lowering effects of ACE inhibitors, beta-blockers, calcium channel blockers, and alpha-blockers.
Other sympathomimetics (pseudoephedrine, ephedrine)
moderateAdditive cardiovascular effects including increased blood pressure and heart rate. Avoid concurrent use.
Yohimbe/yohimbine
majorPharmacodynamic synergism; risk of acute hypertensive episode. Contraindicated.
Thyroid medications (levothyroxine)
moderateEnhanced pressor effects in hyperthyroid patients or those on thyroid replacement. Monitor carefully.
Phenylephrine is at a crossroads in 2026. For decades, it was the default OTC decongestant found in hundreds of cold and allergy products. The FDA's proposed removal of oral phenylephrine from the OTC monograph — based on evidence that the pill form simply doesn't work for nasal congestion — marks a major shift in the OTC cold medicine landscape. Patients who have been relying on Sudafed PE may not have been getting meaningful decongestant relief.
The key takeaways: oral phenylephrine is safe but likely ineffective. Phenylephrine nasal spray is still effective and available. For most patients with acute nasal congestion, pseudoephedrine (behind the pharmacy counter) or oxymetazoline nasal spray (Afrin) are better options. For allergy-related congestion, a corticosteroid spray like Flonase is first-line therapy.
If you're having trouble finding phenylephrine products or any alternative decongestant at pharmacies near you, medfinder can call local pharmacies to check availability and text you the results. It's the fastest way to locate any medication in stock near you.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini